Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
October 10, 2006

DSM Biologics Provides Manufacturing Services to Argenes

  • DSM Biologics and Argenes signed a biopharmaceutical manufacturing agreement. Under the terms of the agreement, DSM Biologics will provide Argenes with full process development services, analytical development services, and manufacturing batches for Argenes’ Anti-Fas IgM Mab.

    Argenes’ Anti-FAS IgM Mab is being developed as an antirheumatic agent. The services will be provided out of DSM Biologics’ manufacturing facility in Groningen, The Netherlands.

  • You’re all set! Thank you for subscribing to GEN Highlights.